List of Studies ( Metabolite:p-Aminobenzoic acid)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST003104 | AN005083 | Metabolomics studies on human cardiac samples | Heart | Human | Heart disease | University of Sydney | abundance |
| ST003252 | AN005328 | Metabolomics studies on mouse cardiac samples on a Western diet | Heart | Mouse | Obesity; Diabetes; Hypertension; Hyperglycemia | University of Sydney | abundance |
| ST003253 | AN005331 | Metabolomics studies on mouse liver samples on a Western diet | Liver | Mouse | Obesity; Diabetes; Hypertension; Hyperglycemia | University of Sydney | abundance |
| ST003072 | AN005030 | Investigation of polar metabolites by targeted LC-MS analysis from mouse adult or embryonic CSF and from adult serum. | Cerebrospinal fluid | Mouse | Boston Childrens Hospital | a.u. | |
| ST003081 | AN005039 | Metabolome changes in embryonic CSF (Part 3) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003084 | AN005042 | Metabolic changes in embryonic CSF (Part 6) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003085 | AN005044 | Metabolome changes in embryonic CSF (Part 7) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003086 | AN005046 | Metabolome changes in embryonic CSF (Part 8) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003087 | AN005048 | Metabolome changes in embryonic CSF (Part 9) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003088 | AN005050 | Metabolome changes in embryonic CSF (Part 10) | Blood | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003088 | AN005050 | Metabolome changes in embryonic CSF (Part 10) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003088 | AN005050 | Metabolome changes in embryonic CSF (Part 10) | Liver | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003088 | AN005051 | Metabolome changes in embryonic CSF (Part 10) | Blood | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003088 | AN005051 | Metabolome changes in embryonic CSF (Part 10) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003088 | AN005051 | Metabolome changes in embryonic CSF (Part 10) | Liver | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003089 | AN005052 | Metabolome changes in embryonic CSF (Part 11) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST003175 | AN005212 | Inactivation of mitochondrial MUL1 E3 ubiquitin ligase inhibits lipogenesis and prevents diet-induced obesity in mice | Liver | Mouse | Obesity; Diabetes; Liver disease | University of Florida | A.U. |
| ST003026 | AN004961 | Untargeted Metabolomics Reveals Unique Biomolecular Signatures in Overweight and Obesity Using UHPLC-ESI-QTOF-MS Analysis | Blood | Human | Obesity | Sharjah Institute for Medical Research | AU |
| ST003039 | AN004986 | A Non-Targeted Metabolomics Comparative Study on Plasma of Pfizer and Sinopharm COVID- 19 Vaccinated individuals, Assessed by (TIMS-QTOF) Mass Spectrometry. | Blood | Human | COVID-19 | Sharjah Institute for Medical Research | AU |
| ST003028 | AN004965 | Chronic stress dampens Lactobacillus johnsonii-mediated tumor suppression to enhance colorectal cancer progression | Colon | Mouse | Cancer | China Pharmaceutical University | count per second (cps) |
| ST003365 | AN005515 | Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003366 | AN005517 | Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro | Synthetic | Other | Cancer | Wistar Institute | Counts per second (cps) |
| ST003367 | AN005519 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003411 | AN005603 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003412 | AN005605 | Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003427 | AN005627 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate | Breast cancer cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003427 | AN005628 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate | Breast cancer cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003428 | AN005629 | Intracellular and medium metabolomics of BT-474 cells treated with rotenone | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003428 | AN005630 | Intracellular and medium metabolomics of BT-474 cells treated with rotenone | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003429 | AN005632 | Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003430 | AN005634 | Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003431 | AN005636 | Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003432 | AN005638 | Intracellular and medium metabolomics of BT-474 cells treated with LW6 | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003433 | AN005640 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 | Cultured cells | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003434 | AN005642 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Blood | Human | Cancer | Wistar Institute | Counts per second (cps) |
| ST003435 | AN005644 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Media, Metabolite extract | Zebra fish | Cancer | Wistar Institute | Counts per second (cps) |
| ST003436 | AN005646 | Pharmacokinetics of Fasnall in NSG mice | Brain, Heart, Liver, Blood | Mouse | Cancer | Wistar Institute | Counts per second (cps) |
| ST003312 | AN005424 | Integrative analysis of serum and fecal metabolome and the microbiome that herald Crohn Disease flare - serum | Blood | Human | Inflammatory bowel disease; Crohn disease | Sheba hospital | normalized metabolite percentage per sample |
| ST003064 | AN005020 | Metabolic responses of Amaranthus caudatus roots and leaves to zinc stress | Plant Leaves and Roots | Plant | K.A. Timiryazev Institute of Plant Physiology RAS, Moscow, Russia | peak areas | |
| ST003313 | AN005425 | Integrative analysis of serum and fecal metabolome and the microbiome that herald Crohn Disease flare - feces | Feces | Human | Inflammatory bowel disease; Crohn disease | Sheba hospital | percentage of metabolites per sample |
| ST003080 | AN005038 | Metabolome changes in embryonic CSF (Part 2) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | ppm |
| ST003482 | AN005718 | Tissue niche influences immune and metabolic profiles to Staphylococcus aureus biofilm infection (Intracellular data) | Intracellular Granulocyte | Mouse | Bacterial infection | UNMC | Relative intensities |
| ST003161 | AN005186 | Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohort | Feces | Human | Inflammatory bowel disease | Sheba hospital | TSS normalized values |
